Details for New Drug Application (NDA): 050724
✉ Email this page to a colleague
The generic ingredient in ABELCET is amphotericin b. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.
Summary for 050724
Tradename: | ABELCET |
Applicant: | Leadiant Biosci Inc |
Ingredient: | amphotericin b |
Patents: | 0 |
Suppliers and Packaging for NDA: 050724
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ABELCET | amphotericin b | INJECTABLE, LIPID COMPLEX;INJECTION | 050724 | NDA | Leadiant Biosciences, Inc. | 57665-101 | 57665-101-41 | 1 VIAL in 1 CARTON (57665-101-41) / 20 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE, LIPID COMPLEX;INJECTION | Strength | 5MG/ML | ||||
Approval Date: | Nov 20, 1995 | TE: | RLD: | Yes |
Expired US Patents for NDA 050724
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Leadiant Biosci Inc | ABELCET | amphotericin b | INJECTABLE, LIPID COMPLEX;INJECTION | 050724-001 | Nov 20, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Leadiant Biosci Inc | ABELCET | amphotericin b | INJECTABLE, LIPID COMPLEX;INJECTION | 050724-001 | Nov 20, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription